Patrick Marroum

2.0k total citations
36 papers, 777 citations indexed

About

Patrick Marroum is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Analytical Chemistry. According to data from OpenAlex, Patrick Marroum has authored 36 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 11 papers in Pharmaceutical Science and 7 papers in Analytical Chemistry. Recurrent topics in Patrick Marroum's work include Drug Solubulity and Delivery Systems (11 papers), Pharmaceutical studies and practices (10 papers) and Analytical Methods in Pharmaceuticals (7 papers). Patrick Marroum is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Pharmaceutical studies and practices (10 papers) and Analytical Methods in Pharmaceuticals (7 papers). Patrick Marroum collaborates with scholars based in United States, Germany and Thailand. Patrick Marroum's co-authors include Jogarao Gobburu, Ramana Uppoor, John Duan, Stephen H. Curry, Hao Xu, Yi Shi, Ping Gao, Natalie D. Eddington, Larry L. Augsburger and Mohamed‐Eslam F. Mohamed and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Patrick Marroum

35 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Marroum United States 17 295 147 125 123 115 36 777
Paul Seo United States 16 347 1.2× 84 0.6× 204 1.6× 101 0.8× 118 1.0× 24 779
Nikunjkumar Patel United Kingdom 19 373 1.3× 98 0.7× 193 1.5× 73 0.6× 105 0.9× 36 795
Alfredo García‐Arieta Spain 16 488 1.7× 103 0.7× 112 0.9× 176 1.4× 163 1.4× 72 996
Paulo Paixão Portugal 14 160 0.5× 103 0.7× 143 1.1× 61 0.5× 57 0.5× 34 608
Andrew Babiskin United States 19 278 0.9× 80 0.5× 241 1.9× 73 0.6× 71 0.6× 49 843
Mira Symillides Greece 19 455 1.5× 55 0.4× 81 0.6× 149 1.2× 116 1.0× 28 718
Alan Parr United States 16 361 1.2× 44 0.3× 98 0.8× 99 0.8× 64 0.6× 41 776
Binfeng Xia United States 12 189 0.6× 123 0.8× 96 0.8× 79 0.6× 50 0.4× 19 470
Walter S. Woltosz United States 7 279 0.9× 174 1.2× 109 0.9× 84 0.7× 56 0.5× 12 616
Oliver Hatley United Kingdom 16 206 0.7× 324 2.2× 206 1.6× 145 1.2× 58 0.5× 27 952

Countries citing papers authored by Patrick Marroum

Since Specialization
Citations

This map shows the geographic impact of Patrick Marroum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Marroum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Marroum more than expected).

Fields of papers citing papers by Patrick Marroum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Marroum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Marroum. The network helps show where Patrick Marroum may publish in the future.

Co-authorship network of co-authors of Patrick Marroum

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Marroum. A scholar is included among the top collaborators of Patrick Marroum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Marroum. Patrick Marroum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marroum, Patrick, et al.. (2024). Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women. Clinical Pharmacology in Drug Development. 13(6). 601–610. 1 indexed citations
2.
Wang, Yamin, Yueli Liu, Rong Deng, et al.. (2024). Venetoclax Clinical Pharmacokinetics After Administration of Crushed, Ground or Whole Tablets. Clinical Therapeutics. 46(10). 752–758. 3 indexed citations
3.
Mukherjee, Dwaipayan, et al.. (2023). Virtual Bioequivalence Assessment of Elagolix Formulations Using Physiologically Based Pharmacokinetic Modeling. The AAPS Journal. 25(3). 30–30. 5 indexed citations
4.
Pang, Yinuo, Ronilda D’Cunha, Afroz S. Mohammad, et al.. (2023). Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease. Clinical Therapeutics. 46(1). 30–39. 5 indexed citations
5.
Badawi, Mohamed, Xin Chen, Patrick Marroum, et al.. (2022). Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet. Clinical Drug Investigation. 42(8). 657–668. 6 indexed citations
6.
Mohamed, Mohamed‐Eslam F., et al.. (2022). Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications: a Case Study from Upadacitinib Development. The AAPS Journal. 24(2). 39–39. 3 indexed citations
7.
Marroum, Patrick, Silpa Nuthalapati, Apurvasena Parikh, et al.. (2018). Industry Perspective on Standardizing Food-Effect Studies for New Drug Development. Clinical Pharmacokinetics. 57(8). 901–909. 2 indexed citations
8.
9.
Polepally, Akshanth R., Haoyu Wang, Patrick Marroum, et al.. (2017). Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection. The AAPS Journal. 19(5). 1523–1535. 1 indexed citations
10.
Mittapalli, Rajendar K., et al.. (2017). Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data. Pharmaceutical Research. 34(7). 1527–1533. 5 indexed citations
11.
12.
Martinez, Marilyn N., Joseph C. Kawalek, Karyn D. Howard, et al.. (2006). Comparison of bovine in vivo bioavailability of two sulfamethazine oral boluses exhibiting different in vitro dissolution profiles. Journal of Veterinary Pharmacology and Therapeutics. 29(6). 459–467. 3 indexed citations
13.
Bhattaram, Venkatesh Atul, Brian Booth, B. Nhi Beasley, et al.. (2005). Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications. The AAPS Journal. 7(3). E503–E512. 95 indexed citations
14.
Jackson, André J., Gabriel J. Robbie, & Patrick Marroum. (2004). Metabolites and Bioequivalence. Clinical Pharmacokinetics. 43(10). 655–672. 27 indexed citations
15.
Marroum, Patrick & Jogarao Gobburu. (2002). The Product Label. Clinical Pharmacokinetics. 41(3). 161–169. 17 indexed citations
16.
Rekhi, Gurvinder Singh, et al.. (2000). Evaluation of “External” Predictability of an In Vitro–In Vivo Correlation for an Extended‐Release Formulation Containing Metoprolol Tartrate. Journal of Pharmaceutical Sciences. 89(10). 1354–1361. 28 indexed citations
17.
Marroum, Patrick. (2000). In vivo drug-drug interaction studies- A survey of all new molecular entities approved from 1987 to 1997. Clinical Pharmacology & Therapeutics. 68(3). 280–285. 22 indexed citations
18.
Balian, John Dikran, et al.. (1999). In vitro metabolic interaction studies: Experience of the Food and Drug Administration. Clinical Pharmacology & Therapeutics. 66(1). 9–15. 44 indexed citations
19.
Marroum, Patrick, et al.. (1994). Pharmacokinetics and pharmacodynamics of acepromazine in horses. American Journal of Veterinary Research. 55(10). 1428–1433. 43 indexed citations
20.
Marroum, Patrick & Stephen H. Curry. (1993). Red Blood Cell Partitioning, Protein Binding and Lipophilicity of Six Phenothiazines. Journal of Pharmacy and Pharmacology. 45(1). 39–42. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Seo Breakdown of academic impact, for papers by Nikunjkumar Patel Breakdown of academic impact, for papers by Alfredo García‐Arieta Breakdown of academic impact, for papers by Paulo Paixão Breakdown of academic impact, for papers by Andrew Babiskin Breakdown of academic impact, for papers by Mira Symillides Breakdown of academic impact, for papers by Alan Parr Breakdown of academic impact, for papers by Binfeng Xia Breakdown of academic impact, for papers by Walter S. Woltosz Breakdown of academic impact, for papers by Oliver Hatley
Rankless by CCL
2026